Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
Lung Carcinoma, Tobacco-Related Carcinoma
About this trial
This is an interventional screening trial for Lung Carcinoma
Eligibility Criteria
Inclusion Criteria: PRACTICE LEVEL: Primary care practice (family medicine, geriatrics, internal medicine) in one of the 4 participating health systems Practice using the main electronic medical record (EMR) of each system, in order to run appropriate patient recruitment reports Practice with at least 50% of practice providers (physicians and advanced care providers) consenting to participate PATIENT LEVEL: Have an office or telemedicine established patient visit scheduled with a primary care provider in one of the participating practices within next 14 to 25 days 50 to 77 years of age Have at least a 20-pack-year smoking history (based on self-report at baseline eligibility assessment) Currently smoke or have quit smoking within the past 15 years (based on self-report at baseline eligibility assessment) Able to communicate in English or Spanish (determined at baseline eligibility assessment) Exclusion Criteria: PATIENT OUTREACH: Any lung computed tomography (CT) or low-dose computed tomography (LDCT) scan in the past 11 months, current procedural terminology (CPT) Codes are as follows G0297 - LDCT screening 71250 - CT w/o contrast 71260 - CT w/ contrast 71270 - CT with and w/o contrast 71275 - CT angiography chest 78815 - Positron emission tomography computed tomography (PET CT) skull base to mid-thigh 78816 - PET CT whole body Prior history of lung cancer (The patient's problem list includes a problem with an international classification of diseases (ICD10) code of "Z85.118" or one beginning with "C34.", or by self-report at baseline eligibility assessment) Recent hospitalization (Admission date within the last 60 days listed in electronic health record (EHR), or by self-report at baseline eligibility assessment) Dementia (diagnosis codes F03.90 or F03.91) in EHR
Sites / Locations
- Sidney Kimmel Cancer Center at Thomas Jefferson University
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Active Comparator
Experimental
Active Comparator
Group A (Providers): (survey, online educational activity)
Group B (Providers): (survey)
Group A (Patients): (EHR, educational activity, counseling))
Group B (Patients): (survey)
Participants complete survey on study. Participants undergo online educational activity on study. Participants undergo distance learning on study.
Participants complete survey at baseline and end of study survey.
Patients undergo EHR review on study. Patients undergo educational activity on study. Patients also undergo SDM counseling once on study.
Patients undergo EHR review on study and complete telephone survey throughout the trial.